Source link : https://newshealth.biz/health-news/chemo-free-doublet-in-first-line-boosts-pfs-in-triple-negative-breast-cancer/
(MedPage Today) — CHICAGO — Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line treatment significantly reduced the risk of progression or death in patients with PD-L1-positive… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115829 Author : Publish date : 2025-05-31 12:00:00 Copyright for syndicated content belongs to the linked Source.
The post Chemo-Free Doublet in First-Line Boosts PFS in Triple-Negative Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-31 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8